Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects

NCT07169240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects (HS)

Interventions

DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: BT-114143
DRUG: 0.9% Sodium Chloride Injection as Placebo

Sponsor

ScinnoHub Pharmaceutical Co., Ltd.

Collaborators

[object Object]